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SUMMARY. Human red cells incubated with a solution containing 6% 2-aminoethyl- 
isothiouronium bromide (AET) lose activity of antigens that are part of, or related to, 
the Kell blood group system. However, Kx antigen is not inactivated. Studies on a 
wide range of other blood-group antigens show no other evidence of changes and 
AET appears to react specifically with red-cell membrane structures that have Kell 
activity. The AET procedure produces an artificial KO red cell that can be used in 
blood group serology, and allows easy recognition of antibodies that are associated 
with the Kell system. 
AET has been used by other workers to produce a red cell that has many 
serological and biochemical characteristics of a PNH cell. Our studies on red cells 
from PNH patients have not shown any changes in Kell blood-group antigens. 
Treatment of human red cells with the compound 2-aminoethylisothiouronium bromide 
(AET) modifies the cell membrane and greatly enhances sensitivity of the cells to the lytic 
action of complement (Sirchia et al, 1965: Sirchia & Dacie, 1967). The membrane lesion that 
is induced by AET closely resembles that which occurs naturally in paroxysmal nocturnal 
haemoglobinuria (PNH) (Sirchia & Ferrone, 1972). AET treatment has been used to 
reproduce in vitro a PNH-like cellular defect and such cells have been extensively studied 
(Canellos et nl, 19 70: De Sandre et al, 19 70; Ferrone et al, 19 72; Burapakulsolsri et al, 19 79). 
The Kell blood group system has greatly increased in its recognized complexity during the 
past few years and presently comprises 22 antigens that are part of, or related to, the system 
(Issitt & Issitt, 1975; Marsh, 1975; Sabo et al, 1979; Yamaguchi et al, 1979). Kell is a system 
of major clinical importance and immunization to Kell-system antigens is a fairly common 
sequel to blood transfusion (Kornstad & Heisto. 1957; Giblett, 1961). In addition, the Kell 
group has an important role in maintenance of red-cell membrane integrity, for cells of the 
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McLeod phenotype in this system have abnormal morphology, and individuals of this blood 
type have a permanent haemolytic state (Wimer et al. 1977; Symmans et al, 1979). 
We have found that red cells incubated with AET undergo specific inactivation of antigens 
in the Kell blood group, but antigens from a wide range of other blood groups are not affected. 
The finding contributes information to several areas of Kell blood-group involvement, and 
provides a practical procedure that facilitates laboratory investigation of Kell-related 
problems. This report presents data from serological aspects of this investigation. 
MATERIALS AND METHODS 
Serological tests were made by standard procedures using 3-5% red cell suspensions and 
allowing 30 min incubation times. Antiglobulin reagents were of commercial origin. 
Blood-group antisera and red-cell samples were from our own reference collections; some 
were received through the SCARF international exchange programme. Most red-cell samples 
were stored frozen in liquid nitrogen. Antibody elution from sensitized red cells was made 
using a modification of Rubin's (1963) ether method. AET was obtained from Calbiochem, 
Behring Corp., California. It has a molecular weight of 281 Daltons and is stable in the dry 
state at room temperature. 
Preparation of AET solution. Following our initial observations in the Kell system, 
preliminary studies were made into the effect of variation in AET concentration, pH, reaction 
time and temperature. They showed that 6% AET dissolved in distilled water, and adjusted to 
pH 8.0 by addition of 5 N NaOH, was optimum. One volume of washed packed red cells was 
mixed with 4 volumes of this solution and incubated at 3 7°C for 20 min. The reaction was 
stopped by washing the cells in phosphate-buffered saline at pH 7.0. The first wash fluids 
usually showed haemolysis, and washing was continued until the supernatant fluid was 
clear (four to six washes). Treated cells were kept refrigerated and used for up to 24 h. The 
alkaline AET solution should be prepared immediately before use. 
RESULTS 
Inactivation of Kell antigens 
Appropriate red cells have been tested in parallel studies with AET-treated and untreated 
cells, using IgG Kell antisera by the indirect antiglobulin test. The following Kell-system 
antigens are inactivated by AET: K, k, Kp", Kpb, Kp", Js", Jsb, K 1  7(Wka), K 1 1 ,  Ul", K12, K13, 
K14, K18, K19, K20, K22 and Ku. In the case of K, k and Kpb many examples of the 
antibodies have been used. Other specificities have been studied with duplicate antisera, 
except for KpC, K17, Ul", K 1 3  and K22, where only one example of each antibody was 
available. Antibody absorption and elution studies using anti-k, anti-Kpb, anti-Jsb and 
anti-Ku show that while untreated reactive red cells react strongly and yield potent eluates, 
the same cells treated with AET do not react: eluates prepared from them are inactive. 
The Kx (K15) antigen is related to the Kell system although it is not a product of the Kell 
gene (Marsh et al, 1975b). To study the effect of AET on Kx antigen, an anti-KIA serum, 
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containing anti-Kx and anti-Km, was absorbed with KO (Kx positive) cells and an eluate 
prepared from them. Tests with this eluate against AET-treated and untreated cells of 
common Kell type showed that Kx was not inactivated by AET, but, on the contrary, treated 
cells appeared to have enhanced activity. Table I shows results obtained in these experiments 
using anti-Kx. In further studies, monospecific anti-Km present in the serum of a non-CGD 
McLeod-type man who had been immunized by blood transfusion, did not react with 
AET-treated red cells. 
Other antigens on AET-treuted red cells 
To investigate the specificity of AET inactivation of red cell antigens appropriate cells have 
been tested, before and after treatment, with antibodies to the following blood-group 
antigens: A, AI, B, H, I, i, Lea, Leb, Sd”, Sd”, Spl(Pr), M, N, S, s, U, PI, ‘Tj”’, D, C, c, Cw, E, e. 
Rh29. Lu“, Lub, Lu3, Fy”, Fyb. Fy3, Jk”, Jkb, Jk3, Xg”, Co“, Cob, Ena, Wr”, Wrb. Dia, Dib, Ata, Cs“, 
Lan, Ch”, Rg”, Vel and Yt”. In all cases AET-treated cells reacted as strongly as did untreated 
cells. 
The Gerbich (Ge) antigen has an association with the Kell system, for some Ge-negative 
cells have weak Kell antigens (Muller et nl, 19 7 3 ) .  The nature of the association is unknown. 
Direct tests with three anti-Ge sera gave strong reactions with AET-treated cells and in a 
titration study the scores of treated and untreated cells were the same (Table 11). In further 
titration studies using anti-Fy”, anti-D, anti-M, anti-Lu3, anti-Dib and anti-Jk”, the results 
given by treated and untreated cells were indistinguishable. Table I1 shows representative 
results obtained from titration studies with various antibodies against AET-treated red cells. 
In antibody absorption and elution studies, using anti-Fy“ and anti-U, potent eluates were 
obtained from AET-treated red cells. AET did not induce formation of new blood group 
antigenic configurations in the systems tested; treated Fy(a - )  red cells did not become 
Fy( a + ), Jk( a - ) red cells did not become Jk(a + ), and D-negative red cells did not become 
D-positive. 
Table I. Results obtained from titrating anti-Kx against 
AET-treated and untreated red cells 
Anti-Kx 
Reciprocals of dilutions 
Total 
Test cells 1 2 4 8 score 
K - k + untreated 5 0 0 0 5 
K - k +  AET-treated 7 6 5 0 18 
KO untreated / 5 4 0 16 
KO AET-treated 7 5 5 0 17 
- 
Tests by antiglobulin method. Scoring system of Marsh 
(1 972). 
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Table 11. Results of titrating blood group alloantibodies against 
untreated and AET-treated red cells. These data are representative 
of many studies; appropriate red cells were used for each antibody 
specificity. 
Reciprocals of antibody dilutions 
Total 
Test cells 1 2 4 8 16 32 64 128 score 
~~ 
Anti-Fya 
Untreated 9 8 5 4 2 1 0 0 29 
AET-treated 11 7 7 3 2 0 0 0 30 
Untreated 12 12 11 10 8 0 0 0 53 
AET-treated 1 2  12 10 10 8 6 0 0 58 
Untreated 10 10 9 7 4 0 0 0 40 
AET-treated 9 9 8 5 4 0 0 0 3 5  
Untreated 11 10 10 7 5 2 0 0 45 
AET-treated 0 0 0 0 0 0 0 0 0 
Untreated 10 10 8 7 6 4 2 0 47 
AET-treated 0 0 0 0 0 0 0 0 0 
Untreated 12 10 10 10 8 6 4 1 61 






Tests by antiglobulin method. 
AET treatment of KO and McLeod phenotype red cells 
KO red cells, which lack all antigens of the Kell system except Kx (Chown et al, 195 7; Marsh et 
al, 1975b), do not become reactive with anti-K, anti-Kpb, anti-Jsb or anti-Ku after treatment 
with AET. However, the cells retain unchanged their strong reactivity with anti-Kx. 
McLeod-phenotype red cells have weak Kell antigens (Allen et al, 1961). AET-treated 
McLeod-type red cells do not react with anti-k, anti-Kpb or anti-Js" either by direct testing or 
by an antibody absorption and elution procedure. The treated cells do not react with anti-KL. 
Autoimmune antibodies with specificity in  the Kell system 
In rare cases of IgG autoimmune haemolytic anaemia (AIHA) the autoantibody has 
specificity for an antigen in the Kell system (Seyfried et al, 1 9  72; Beck et al, 1979; Marsh et al, 
19 79a). We have tested four examples of auto-anti-K and two examples of auto-anti-Kpb 
against AET-treated red cells. In each case activity of the definitive red cell antigen was 
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eliminated. In addition, we studied two patients whose blood contained an autoantibody that 
reacted with all random and most selected bloods, but did not react with KO cells. In both 
cases, specificity for a known high-incidence antigen in the Kell group has been excluded. 
Serological details of one of these patients have been reported (Marsh et al, 1979b). Neither of 
these autoantibodies reacted with AET-treated red cells of common Kell type. 
Non-spec$c agglutination 
Red cells treated with AET may give weak non-specific reactions in the antiglobulin test when 
polyspecific antiglobulin reagents are used. Tests with fresh sera from 30 random blood 
donors showed no agglutination of saline-suspended AET-treated group 0 red cells, but 
varied reactions scoring up to 2 or 3 (Marsh, 1972) in the indirect antiglobulin test. No 
reactions were obtained when monospecific anti-IgG antiglobulin reagent was used. Weak 
reactions with anti-C3 antiglobulin reagent indicate that the phenomenon is caused by 
complement that binds to the membrane of treated red cells. Treated cells do not react with 
lectins prepared from Arachis hgpogeu, Snlvia sclarea, Salvia horminum, Phaseolus lirnensis, or 
with the BSII lectin prepared from Bandeiruea sirnplicifolia seeds. Weak variable reactions were 
obtained with some preparations of Glgcine soja lectin. 
As a precaution against non-specific agglutination, most tests in this investigation using 
the antiglobulin method were made with anti-IgG reagent. In addition, confirmatory tests 
have been made with antibodies representative of the ABO, Rh, MN, Duffy and Kidd blood 
groups that were isolated by absorption and elution from reactive red cells. All of our data 
show that Kell antigens are inactivated by AET, but antigens of other blood group systems are 
unchanged. 
PNH red cells 
The observation by other workers that AET induces a PNH-like lesion on red cells prompted 
an investigation to determine whether Kell antigens are modified on red cells from patients 
with PNH. Clinical colleagues have kindly supplied us with blood samples and we have 
studied nine patients with PNH. Each patient was of common Kell phenotype. In titration 
studies using anti-k, anti-Kpb, anti-Jsb and anti-Ku, scores comparable to positive controls 
were obtained. No evidence of a mixed red-cell population was found in any of these studies. 
Red cells from three patients were treated with AET. Subsequent tests showed that 
Kell-system blood-group antigens were inactivated. These patients had transfusion histories 
that ranged from a few transfusions to several hundred. The serum of six of the nine cases 
contained anti-K. 
Cellular morphological changes caused f~g AET 
Red cells treated with 6% AET show some fragmentation when studied by light microscopy, 
but no evidence of acanthocytosis or other gross changes in morphology. 
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DISCUSSION 
2-Aminoethylisothiouronium bromide has been widely used to produce in vitro red cells that 
have PNH-like activity. Such cells have abnormal sensitivity to the lytic action of 
complement, and react as do PNH cells in the acidified serum and sucrose haemolysis tests 
(Sirchia et aI, 1965; Ferrone et al, 1972). The cells also show the reduced acetylcholinesterase 
activity that is characteristic of the cell-membrane defect in PNH (Sirchia et al, 1966). 
However, the membrane change that is induced by AET is not the same as that present in 
PNH for Kell antigens of AET-treated cells are inactive, but Kell antigens of PNH red cells are 
not. 
Lewis et a1 (1971) have compared the morphology of PNH red cells with the morphology 
of red cells treated with AET, using scanning and transmission electron microscopy. AET 
treatment induced spherical shape changes with surface craters and pits, while natural PNH 
cells showed electron-dense material scattered over the cell with fine surface pitting. They 
concluded that the morphological changes seen in both cells were similar but not identical. 
We have found that 6% AET does not induce gross changes in red-cell morphology, when 
viewed by light microscopy, and gives no evidence of the acanthocytic changes that are 
characteristic of the McLeod Kell variant. 
The mechanism by which AET affects cell-membrane characteristics, either in creating a 
PNH-like defect or in inactivating Kell-system antigens, is unknown. Nor is it known whether 
the two defects are related, or are unrelated coincidental occurrences. 
From the blood group viewpoint, the finding that Kell-system antigens are specifically 
inactivated by AET makes several theoretical and practical contributions. Four sets of 
antigens, K-k, Kpa-Kpb-Kp", Jsa-]sb and K17-Kl1, and one low-incidence antigen, UP, are 
known to be controlled by the Kell gene. However, a number of high-incidence antibodies 
have been described that react with random bloods but not with KO cells, and have all other 
serological characteristics typical of Kell antibodies (Issitt & Issitt, 19  75; Marsh, 1975; Sabo ef 
~1,1979) .  Proof that the antigens are products of the Kell gene has not, thus far, been possible. 
K12, K 1 3 ,  K14, K18, K19, K20 (Km) and K22 are all different high-incidence antigens ofthis 
kind. But the finding that these antigens are inactivated by AET is evidence that they have a 
close biochemical relationship with Kell and makes it unlikely that they are not part of the 
Kell system. Genetic proof by pedigree analysis that these antigens are controlled by the Kell 
gene awaits the finding of antibodies that define hypothetical low-incidence antigens that are 
produced by alleles. Here again the AET procedure may help, for if a 'new' low-incidence 
antigen is inactivated by AET it is probably part of the Kell complex. 
From the practical immunohaematology viewpoint the AET procedure provides an 
artificial KO red cell that can be used to determine whether antibodies to high-incidence 
antigens have specificity in the Kell system. Furthermore, it is often difficult to determine 
whether antisera such as anti-k, anti-Kpb or anti-]sb contain other alloantibodies. Tests 
against a panel of AET-treated red cells will prevent activity of the Kell antibody and allow 
other alloantibodies to be recognized. Table I11 shows results from investigation of a serum 
containing anti-Kpb and anti-Fya, that illustrates this application. 
The studies on specific Kell antibodies found in autoimmune situations show that in these 
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Table 111. Studies on a multispecific antiserum utilizing 
AET-treated and untreated red cells 
1 1 3  
Test results 
Untreated AET-treated 
Panel cell phenotype 
Kp" Kpb Fy" Fyb red cells red cells 
~~ 
O + + +  + + 
0 + 0 +  + 0 
0 + + +  + + 
0 + O +  + 0 
+ + + o  + + 
+ o o +  0 0 
Tests by antiglobulin method. The serum contains 
anti-Kpb and anti-Fya. 
cases, also, the reactive red-cell antigen is inactivated by AET. Similarly, the autoantibodies 
that react with all bloods except those of K,, type, are non-reactive with AET-treated red cells. 
The specificity of some of these antibodies may be anti-Ku, but it is also possible that they 
define other, as yet unknown, high-incidence Kell-related antigens. However, it must be 
concluded that these autoantibodies and antigens all have a close serological and 
biochemical relationship to the Kell system. 
Although Kx antigen is associated with the Kell blood group it is not a product of a gene at 
the Kell locus. Xk, the locus that controls Kx synthesis, is X-linked (Marsh et al, 1975a; 
Marsh, 19 75,19 78). Other studies have suggested that Kx substance is a precursor utilized in 
the normal Kell biosynthetic pathway (Marsh et al, 1975b). The AET data are not in 
disagreement with this hypothesis, for they show that Kx is not inactivated by AET, but 
treated red cells of common Kell type have enhanced reactivity with anti-Kx. 
The weak Kell antigens present on red cells of McLeod phenotype differ qualitatively from 
the Kell antigens present on normal red cells (Marsh et al, 1975b). However, McLeod-type 
Kell antigens are also inactivated by AET. The observation that anti-Km (K20) does not react 
with AET-treated red cells indicates that Km is a part of the Kell complex, and supports the 
conclusion of White et al(1980) who considered Km to be a product of all Kell genes utilizing 
normal Kx-positive precursor. 
Considering the known serological and genetic information on the Kell blood group, 
together with data from our present investigation, we think it likely that AET specifically 
inactivates antigens that are products of the gene, or genes, at the Kell locus. Conversely, an 
antigen that is not inactivated by AET is probably not coded for by a gene at the Kell locus. 
Biochemical studies directed towards elucidating the mechanism by which AET inactivates 
antigens of the Kell blood group are in progress. 
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